Crouch Ashley, Chaudhri Aysha, Khan Sonya, Ma Maggie, Vu Ngoc, Towers William
Department of Pharmacy, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Department of Endocrine Neoplasia and Hormonal Disorders, MD Anderson Cancer Center, 5927 Almeda Rd, Unit 21414, Houston, TX, 77004, USA.
Curr Oncol Rep. 2025 May 28. doi: 10.1007/s11912-025-01685-z.
Hypercalcemia of malignancy is one of the most common metabolic disorders in patients with cancer and is associated with significant morbidity and mortality. This narrative review summarizes pathophysiology, clinical presentation, diagnostic strategies, and therapies available for the management of hypercalcemia of malignancy in acutely ill adult patients.
We reviewed both classic and recent literature to provide practical recommendations for managing cancer-related hypercalcemia. Our findings are presented in the context of recently published societal guidelines. Timely identification and treatment of acute hypercalcemia of malignancy is vital. Understanding of the underlying disease processes and available therapies is needed to optimize patient care and healthcare resource utilization.
恶性肿瘤相关性高钙血症是癌症患者最常见的代谢紊乱之一,与显著的发病率和死亡率相关。本叙述性综述总结了急性病成年患者恶性肿瘤相关性高钙血症的病理生理学、临床表现、诊断策略及可用治疗方法。
我们回顾了经典文献和近期文献,以提供管理癌症相关高钙血症的实用建议。我们的研究结果是在最近发布的社会指南背景下呈现的。及时识别和治疗急性恶性肿瘤相关性高钙血症至关重要。需要了解潜在的疾病过程和可用治疗方法,以优化患者护理和医疗资源利用。